🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
90 Servings
Other Combinations Product Type
60% Evidence Coverage

Supplement Facts — Evidence Check

50 mg (15% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 50mg
1 mg (250% DV)
✅ 2.5× RDA — within safe limits 📚 225 studies (Tier A: 10, B: 105)
RDA 0.4mg This product: 1mg UL 1.0mg
Iron
90 mg (15% DV)
12 mcg (15% DV)
📊 5.0× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.012mg
Vitamin C
120 mg (15% DV)

Other Ingredients

Microcrystalline Cellulose Di Calcium Phosphate Tripotassium Citrate Sodium Carboxymethyl Cellulose Acacia Povidone K30 Croscarmellose Sodium fumed Silica Stearic Acid Magnesium Stearate Citric Acid Dextrin Dextrose Lecithin Sodium Citrate

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Recommended Use One tablet daily or as directed by a physician. Do not chew tablet.

⚠️ Warnings & Precautions

Warning: Accidental overdose of iron-containing products is a leading cause of fetal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Call your doctor about side effects. You may report side effects by calling 888 9 TRIGEN (888-987-4436).

Keep out of the reach of children.

🧪 Formulation Notes

With 90 mg carbonyl iron

Additional Information

Storage Store at 20(0)-25(0)C (68(0)-77(0)F, excursions permitted to 15(0)-30(0)C (59(0)-86(0)F) [See USP controlled room temperature].

Description FerraPlus90 is a dark grey, oval, film-coated tablet, debassed "TL012".

Indications And Usage FerraPlus 90 is indicated for the treatment of all anemias that are responsive to oral iron therapy. These Include: Hypochromic anemia associated with pregnancy, chronic and/or acute blood loss, metabolic disease, post-surgical convalescence, and dietary needs.

Each Dark Grey Film-Coated Tablet For Oral Administration Contains:

Rev. 07/13

13811-012-90 Rx only

Product Details

UPC / SKU 3 13811 01290 3
DSLD Entry Date 2018-02-23
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 82219
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →